Results 261 to 270 of about 7,850 (302)
Some of the next articles are maybe not open access.
Assessing the benefits of anti-emetic innovation
Anti-Cancer Drugs, 1993This paper reviews recent anti-emetic developments, with particular reference to the 5-HT3 receptor antagonists. These drugs are at least as effective as conventional regimens for controlling acute nausea and vomiting in patients receiving highly or moderately emetogenic chemotherapy and abdominal radiotherapy.
openaire +2 more sources
Methodology in anti-emetic trials.
European journal of cancer (Oxford, England : 1990), 1991Major progress in the ability to control chemotherapy-induced emesis has been made over the past 10 years. One of the several factors contributing to this improved control has been the development of accurate assessment methodology. The application of proper study methodology fostered the identification of active single agents and led to the formation ...
R J, Gralla +3 more
openaire +1 more source
Emetics and antiemetics are two classes of medications that serve opposite purposes in managing nausea and vomiting. Emetics, such as ipecac syrup, induce vomiting and are used primarily in certain poisoning cases to expel ingested toxins from the stomach. However, their use has declined due to the potential risks and the availability of more effective
openaire +1 more source
openaire +1 more source
An outline of anti-emetic treatment.
European journal of cancer & clinical oncology, 1990With the advent of new chemotherapeutic agents, and their well-known side effect of emesis, the need for a greater facility with anti-emetics has emerged. As well as the common problem of chemotherapy-induced emesis, other problems have become apparent such as delayed emesis and anticipatory emesis.
openaire +1 more source